Algo version: 0.98b
Organon & Co. is listed at the NYSE Exchange
Organon & Co. [OGN]
NYSE Sector: Healthcare Industry:Drug Manufacturers - General

Is Organon & Co. stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Organon & Co. pays dividends. Last time was Thursday 12th of September 2024 where the investors holding the stock on Friday 16th of August 2024 were paid $0.28 per share. Over the last 13 times between 2021 and 2024, Organon & Co. has paid $3.64 with an average of $0.28 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Organon & Co. 10 years ago, but if you had invested on Friday 14th of May 2021 when the price was $33.25, you would have made a loss of $-12.76 per share or -38.38%

Yes, the average daily trading liquidity for Organon & Co. is $1.67 million. You should therefore be able to get in and out of your positions relatively fast.

Organon & Co. has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.09, the company's ability to pay off the debt is limited. Organon & Co. has a good net profit margin of 16.50% and should have high tolerances against inflation.

We have calculated the inflation risk for Organon & Co. to be medium [0.7 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.